Search

SareptAssist
SareptAssist
A tale of two interns: Meet Kate & Katherine, rare disease advocates and members of Sarepta’s Patient Affairs team
Sarepta Therapeutics to Announce Second Quarter 2023 Financial Results
Sarepta Therapeutics Announces Sale of Priority Review Voucher for $102 million
What’s in a dose? Gene therapy dosing explained (Video)
Sarepta Therapeutics Announces Second Quarter 2023 Financial Results and Recent Corporate Developments
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quest Diagnostics Granted FDA Breakthrough Designation for its Adeno-associated virus (AAV) Test
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)